Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126884201 | 12688420 | 1 | I | 20160612 | 20160826 | 20160826 | PER | US-ASTRAZENECA-2016SE64900 | ASTRAZENECA | 0.00 | F | Y | 188.70000 | KG | 20160826 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126884201 | 12688420 | 1 | PS | BYDUREON | EXENATIDE | 1 | Oral | U | U | 22200 | 2 | MG | /wk | ||||||
126884201 | 12688420 | 2 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | U | U | 0 | 20 | MG | TABLET | QD | |||||
126884201 | 12688420 | 3 | C | ATORDASTIN | 2 | Oral | U | 0 | 20 | MG | QD | ||||||||
126884201 | 12688420 | 4 | C | HYDROCORD | 2 | Oral | U | 0 | 7.5 | MG | |||||||||
126884201 | 12688420 | 5 | C | JANUVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | U | 0 | 25 | MG | QD | |||||||
126884201 | 12688420 | 6 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | U | 0 | 10 | MG | QD | |||||||
126884201 | 12688420 | 7 | C | CARBEDILOL | 2 | Oral | U | 0 | 25 | MG | Q12H | ||||||||
126884201 | 12688420 | 8 | C | DIGOXIN. | DIGOXIN | 1 | Oral | U | 0 | 25 | MG | QD | |||||||
126884201 | 12688420 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Oral | U | 0 | 81 | MG | QD | |||||||
126884201 | 12688420 | 10 | C | POTASSIUM | POTASSIUM | 1 | Oral | U | 0 | 10 | MG | QD | |||||||
126884201 | 12688420 | 11 | C | TRADJENTA | LINAGLIPTIN | 1 | Oral | U | 0 | 5 | MG | ||||||||
126884201 | 12688420 | 12 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | U | 0 | 100 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126884201 | 12688420 | 1 | Diabetes mellitus |
126884201 | 12688420 | 2 | Blood pressure abnormal |
126884201 | 12688420 | 4 | Back pain |
126884201 | 12688420 | 5 | Diabetes mellitus |
126884201 | 12688420 | 6 | Diabetes mellitus |
126884201 | 12688420 | 7 | Heart rate increased |
126884201 | 12688420 | 8 | Heart rate increased |
126884201 | 12688420 | 9 | Blood disorder |
126884201 | 12688420 | 10 | Blood disorder |
126884201 | 12688420 | 11 | Blood glucose abnormal |
126884201 | 12688420 | 12 | Thyroid disorder |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126884201 | 12688420 | Abdominal pain upper | |
126884201 | 12688420 | Chest pain | |
126884201 | 12688420 | Diarrhoea | |
126884201 | 12688420 | Headache | |
126884201 | 12688420 | Heart rate increased | |
126884201 | 12688420 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126884201 | 12688420 | 1 | 20160602 | 0 | ||
126884201 | 12688420 | 2 | 2011 | 0 | ||
126884201 | 12688420 | 3 | 1999 | 0 | ||
126884201 | 12688420 | 4 | 1998 | 0 | ||
126884201 | 12688420 | 5 | 20160602 | 0 | ||
126884201 | 12688420 | 6 | 2012 | 0 | ||
126884201 | 12688420 | 7 | 2011 | 0 | ||
126884201 | 12688420 | 8 | 2011 | 0 | ||
126884201 | 12688420 | 9 | 2011 | 0 | ||
126884201 | 12688420 | 10 | 2011 | 0 | ||
126884201 | 12688420 | 11 | 201603 | 0 | ||
126884201 | 12688420 | 12 | 2011 | 0 |